- Home
- RMTI vs DYAI Comparison
RMTI vs DYAI Comparison
Compare RMTI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- DYAI
- Stock Information
- Founded
- RMTI 1994
- DYAI 1979
- Country
- RMTI United States
- DYAI United States
- Employees
- RMTI N/A
- DYAI N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMTI Health Care
- DYAI Health Care
- Exchange
- RMTI Nasdaq
- DYAI Nasdaq
- Market Cap
- RMTI 32.5M
- DYAI 28.3M
- IPO Year
- RMTI 1998
- DYAI 2004
- Fundamental
- Price
- RMTI $1.15
- DYAI $0.98
- Analyst Decision
- RMTI Strong Buy
- DYAI Strong Buy
- Analyst Count
- RMTI 2
- DYAI 1
- Target Price
- RMTI $4.00
- DYAI $6.00
- AVG Volume (30 Days)
- RMTI 438.6K
- DYAI 63.9K
- Earning Date
- RMTI 08-07-2025
- DYAI 08-12-2025
- Dividend Yield
- RMTI N/A
- DYAI N/A
- EPS Growth
- RMTI N/A
- DYAI N/A
- EPS
- RMTI N/A
- DYAI N/A
- Revenue
- RMTI $97,727,000.00
- DYAI $3,554,344.00
- Revenue This Year
- RMTI N/A
- DYAI $22.56
- Revenue Next Year
- RMTI $11.16
- DYAI $30.95
- P/E Ratio
- RMTI N/A
- DYAI N/A
- Revenue Growth
- RMTI 12.82
- DYAI 57.59
- 52 Week Low
- RMTI $0.78
- DYAI $0.91
- 52 Week High
- RMTI $5.15
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- RMTI 74.79
- DYAI 53.08
- Support Level
- RMTI $0.80
- DYAI $0.91
- Resistance Level
- RMTI $0.87
- DYAI $0.99
- Average True Range (ATR)
- RMTI 0.08
- DYAI 0.06
- MACD
- RMTI 0.05
- DYAI 0.01
- Stochastic Oscillator
- RMTI 79.69
- DYAI 59.93
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.